Evaluating Work Impairment as a Source of Financial Toxicity in Cancer Healthcare and Negative Impacts on Health Status

How the socioeconomic factors intersect for a particular patient can determine their susceptibility to financial toxicity, what costs they will encounter during treatment, the type and quality of their care, and the potential work impairments they face. The primary goal of this study was to evaluate financial factors leading to worsening health outcomes by the cancer subtype. A logistic model predicting worsening health outcomes while assessing the most influential economic factors was constructed by the University of Michigan Health and Retirement Study. A forward stepwise regression procedure was implemented to identify the social risk factors that impact health status. Stepwise regression was done on data subsets based on the cancer types of lung, breast, prostate, and colon cancer to determine whether significant predictors of worsening health status were different or the same across cancer types. Independent covariate analysis was also conducted to cross-validate our model. On the basis of the model fit statistics, the two-factor model has the best fit, that is, the lowest AIC among potential models of 3270.56, percent concordance of 64.7, and a C-statistics of 0.65. The two-factor model used work impairment and out-of-pocket costs, significantly contributing to worsening health outcomes. Covariate analysis demonstrated that younger patients with cancer experienced more financial burdens leading to worsening health outcomes than elderly patients aged 65 years and above. Work impairment and high out-of-pocket costs were significantly associated with worsening health outcomes among cancer patients. Matching the participants who need the most financial help with appropriate resources is essential to mitigate the financial burden. Significance: Among patients with cancer, work impairment and out-of-pocket are the two primary factors contributing to adverse health outcomes. Women, African American or other races, the Hispanic population, and younger individuals have encountered higher work impairment and out-of-pocket costs due to cancer than their counterparts.

[1]  M. Jefford,et al.  Return to work in head and neck cancer survivors: a systematic review , 2022, Journal of Cancer Survivorship.

[2]  O. Wouters,et al.  Association of Research and Development Investments With Treatment Costs for New Drugs Approved From 2009 to 2018 , 2022, JAMA network open.

[3]  S. Dusetzina,et al.  Financial Toxicity of Cancer Treatment. , 2022, JAMA oncology.

[4]  Wanqing Chen,et al.  Cancer statistics in China and United States, 2022: profiles, trends, and determinants , 2022, Chinese medical journal.

[5]  A. Jemal,et al.  Annual Report to the Nation on the Status of Cancer, Part 2: Patient Economic Burden Associated With Cancer Care , 2021, JNCI Journal of the National Cancer Institute.

[6]  C. de Oliveira,et al.  The Indirect Cost Burden of Cancer Care in Canada: A Systematic Literature Review , 2020, Applied Health Economics and Health Policy.

[7]  F. Hsiao,et al.  Economic burden of cancers in Taiwan: a direct and indirect cost estimate for 2007–2017 , 2020, BMJ Open.

[8]  R. Croyle,et al.  Persistent Poverty and Cancer Mortality Rates: An Analysis of County-Level Poverty Designations , 2020, Cancer Epidemiology, Biomarkers & Prevention.

[9]  J. Weis,et al.  Patient competence in the context of cancer: its dimensions and their relationships with coping, coping self-efficacy, fear of progression, and depression , 2020, Supportive Care in Cancer.

[10]  C. Botella,et al.  Affect Recall Bias: Being Resilient by Distorting Reality , 2020, Cognitive Therapy and Research.

[11]  S. Coughlin Social determinants of colorectal cancer risk, stage, and survival: a systematic review , 2020, International Journal of Colorectal Disease.

[12]  F. Gany,et al.  Impact of Cancer on Employment. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  David Cella,et al.  Financial Burden Among Patients With Lung Cancer in a Publically Funded Health Care System. , 2019, Clinical lung cancer.

[14]  C. Benedict,et al.  The Impact of Financial Toxicity on Psychological Well-Being, Coping Self-Efficacy, and Cost-Coping Behaviors in Young Adults with Cancer. , 2019, Journal of adolescent and young adult oncology.

[15]  C. Powell,et al.  Global Epidemiology of Lung Cancer , 2019, Annals of global health.

[16]  A. Benson,et al.  Financial toxicity in cancer care: Prevalence, causes, consequences, and reduction strategies , 2019, Journal of surgical oncology.

[17]  R. Lawrenson,et al.  Patient and carer perceived barriers to early presentation and diagnosis of lung cancer: a systematic review , 2019, BMC Cancer.

[18]  Tatu Program,et al.  American Lung Association , 2018, Definitions.

[19]  D. Alberts,et al.  Death or Debt? National Estimates of Financial Toxicity in Persons with Newly-Diagnosed Cancer. , 2018, The American journal of medicine.

[20]  G. Samsa,et al.  Going for Broke: A Longitudinal Study of Patient-Reported Financial Sacrifice in Cancer Care. , 2018, Journal of oncology practice.

[21]  Ahmedin Jemal,et al.  Lung Cancer Screening With Low-Dose Computed Tomography in the United States—2010 to 2015 , 2017, JAMA oncology.

[22]  R. Lim End-of-life care in patients with advanced lung cancer , 2016, Therapeutic advances in respiratory disease.

[23]  A. Abernethy,et al.  The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience. , 2013, The oncologist.

[24]  Reza Gharebaghi MD MPH FAAO PhDc,et al.  Poverty as a Risk Factor in Human Cancers , 2013, Iranian journal of public health.

[25]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[26]  Neal J Meropol,et al.  Cost of cancer care: issues and implications. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  W. Crown,et al.  Estimating the cost of cancer: results on the basis of claims data analyses for cancer patients diagnosed with seven types of cancer during 1999 to 2000. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  K. Langa,et al.  Out-of-pocket health-care expenditures among older Americans with cancer. , 2004, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[29]  G. Fisher,et al.  Overview of the Health and Retirement Study and Introduction to the Special Issue. , 2018, Work, aging and retirement.

[30]  M. Fouad,et al.  What do cancer patients worry about when making decisions about treatment? Variation across racial/ethnic groups , 2013, Supportive Care in Cancer.

[31]  友孝 祖父江 National Lung Screening Trialの概要と評価 , 2012 .

[32]  Rascon [The National Cancer Institute]. , 1953, Boletin cultural e informativo - Consejo General de Colegios Medicos de Espana.